-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EtV9IURHQRq4EmweuWWmC/4qlhT+neltlXpnO3Aa/hKZTHPnwT9fLC7GfpfiXMxl JhUf6aD+dXmlllc672FBUw== 0000014272-08-000106.txt : 20080306 0000014272-08-000106.hdr.sgml : 20080306 20080306172741 ACCESSION NUMBER: 0000014272-08-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080304 FILED AS OF DATE: 20080306 DATE AS OF CHANGE: 20080306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORNELIUS JAMES M CENTRAL INDEX KEY: 0001198959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 08672018 BUSINESS ADDRESS: STREET 1: 111 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 cor843.xml X0202 4 2008-03-04 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001198959 CORNELIUS JAMES M BRISTOL-MYERS SQUIBB CORPORATION 345 PARK AVENUE NEW YORK NY 101546 1 1 0 0 Chief Executive Office Executive Option (right to buy) 22.14 2008-03-04 4 A 0 1205996 0 A 2018-03-03 Common Stock, $0.10 par value 1205996.00 1205996.00 D Restricted Stock Units 2008-03-04 4 A 0 83844 0 A Common Stock, $0.10 par value 83844.00 83844.00 D Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest 25% per year, on a cumulative basis, commencing one year after the grant date. Each restricted stock unit converts into one share of common stock upon vesting. One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. By: /s/ Sonia Vora, Attorney-in-Fact 2008-03-06 -----END PRIVACY-ENHANCED MESSAGE-----